Mark Hahn

Mark Hahn

Directeur/Bestuurslid bij ALSP ORCHID ACQUISITION CORPORATION I
63 jaar
Health Technology
Communications
Technology Services

Profiel

Mark W.
Hahn
is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.

Actieve functies van Mark Hahn

BedrijvenFunctieBegin
ALSP ORCHID ACQUISITION CORPORATION I Directeur/Bestuurslid 01-11-2021
Directeur/Bestuurslid -

Eerdere bekende functies van Mark Hahn

BedrijvenFunctieEinde
SOLENO THERAPEUTICS, INC. Directeur/Bestuurslid 15-05-2026
DOVA PHARMACEUTICALS, INC. Financieel Directeur/CFO 12-11-2019
Financieel Directeur/CFO 30-11-2017
Financieel Directeur/CFO 01-11-2017
Financieel Directeur/CFO 01-01-2009
Ervaring van Mark Hahn in detail bekijken

Opleiding van Mark Hahn

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

50

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit15

Consumer Durables

Communications

Commercial Services

Process Industries

Communications

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Services

Finance

  1. Beurs
  2. Insiders
  3. Mark Hahn
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU